Plain-English translation of NCT03582189 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether MRI imaging — a detailed scanning technology — can be used to guide radiation therapy treatments for liver and pancreatic cancers. Researchers want to see if taking MRI scans before each radiation session can help doctors better position the radiation beam and potentially adjust treatment plans in real time. The goal is to make radiation therapy more precise and effective.
Radiation therapy is an important cancer treatment, but doctors can only see so much with standard imaging. This study explores whether better imaging with MRI could help doctors target tumors more accurately while avoiding damage to surrounding healthy tissues — potentially improving outcomes for patients with these difficult-to-treat cancers.
You likely qualify if…
You likely don't qualify if…
You will receive standard radiation therapy as planned by your doctor. During up to 5 of your radiation sessions, you will have an additional MRI scan taken to help guide your treatment. After each MRI scan, you'll complete a brief questionnaire about your experience, and at the end of the study you'll fill out a final survey about your overall satisfaction. The entire study involves just these extra imaging sessions and short questionnaires added to your regular cancer care.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
Canada
Sponsor
University Health Network, Toronto
Enrollment target
~30 participants
Started
July 2018
Primary completion
February 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Edel Sexton
University Health Network, Toronto
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.